Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cellectar Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 22 | −11 |
| SharesConverted for a 1-for-10 split | 665.5K | 636.5K | −28.9K (−4.3%) |
| Value | $3.61M | $2.14M | −$1.47M (−40.7%) |
New holders (2)
Institutions that held Cellectar Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monticello Wealth Management, LLC | 12,000 | $40.0K | 0.00% |
| Benjamin Edwards Inc | 1 | $0 | 0.00% |
Sold out (13)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Northern Trust Corp | 95,438 | $39.0K |
| Citadel Advisors LLC | 68,990 | $28.0K |
| Cozad Asset Management Inc | 56,000 | $23.0K |
| Commonwealth Equity Services, LLC | 36,799 | $14.0K |
| Modera Wealth Management, LLC | 20,000 | $8.00K |
| Commerce Bank | 14,280 | $6.00K |
| Virtu Financial LLC | 15,441 | $6.00K |
| Scotia Capital Inc. | 11,360 | $5.00K |
| Jane Street Group, LLC | 13,543 | $5.00K |
| Johnson Financial Group, Inc. | 5,500 | $2.00K |
| Prospera Financial Services Inc | 5,254 | $2.00K |
| Bank of America Corp | 1,500 | $1.00K |
| Captrust Financial Advisors | 2,000 | $1.00K |